| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/25/2004 | CN1523988A Use of nk-1 receptor antagonists for the treatment of brain, spinal or nerve injury |
| 08/25/2004 | CN1523981A A pharmaceutical tablet having a high API content |
| 08/25/2004 | CN1523979A Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/25/2004 | CN1523041A Bulgaria inquinans polysaccharide, method for preparing the same and pharmaceutical composition using the compound as active component |
| 08/25/2004 | CN1523019A Tricyclic triazolobenzazepine derivatives, process for producing the same, and antiallergic agents |
| 08/25/2004 | CN1522759A Interferon and synergist combined pharmaceutical |
| 08/25/2004 | CN1522754A Extraction of antiviral immune matter for curing sexual disorder and its formulation |
| 08/25/2004 | CN1522723A Novel use of traditional Chinese medicine rabdosia rubeseens and Isodon longitubus |
| 08/25/2004 | CN1522698A Antivirals |
| 08/25/2004 | CN1163503C Virus clearance process |
| 08/25/2004 | CN1163475C 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivative and use as MEK inhibitor thereof |
| 08/25/2004 | CN1163253C Mulberry mistletoe extract for preventing or treating anaphylactic reaction, medicinal composition containing it and its preparing process |
| 08/24/2004 | US6781000 Alpha-ketoamide inhibitors of 20S proteasome |
| 08/24/2004 | US6780970 Peptides for use in the treatment and prevention of diabetes, reperfusion injuries, immunological, cardiovascular and autoimune diseases |
| 08/24/2004 | US6780884 Derivating of tryptamine and analogous compounds and pharmaceutical formulations containing them |
| 08/24/2004 | US6780874 Autoimmune disease; antiinflammatory agents; antiproliferative agent |
| 08/24/2004 | US6780873 Urea substituted imidazoquinolines |
| 08/24/2004 | US6780867 Thienopyrimidines |
| 08/24/2004 | US6780429 With 2'-5' phosphodiester bond content up to 3%; maintains pharmacological action while reducing toxicity |
| 08/24/2004 | US6780416 Bee venom polypeptides and methods of use thereof |
| 08/24/2004 | US6780405 Having first origin of replication conferring low copy number, conferring vector replication using dna polymerase iii, second origin of replication operably linked to first promoter and repressed by chromosome-encoded repressor, as is foreign gene |
| 08/24/2004 | US6780400 Delivery of antiemetics through an inhalation route |
| 08/24/2004 | US6780399 Delivery of stimulants through an inhalation route |
| 08/24/2004 | US6780398 Aqueous nasal formulation |
| 08/24/2004 | US6780324 Preparation of sterile stabilized nanodispersions |
| 08/24/2004 | CA2143610C Use of norastemizole for the treatment of allergic disorders |
| 08/19/2004 | WO2004069876A2 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | WO2004069869A1 Apoptosis-inducing gene and utilization of the same |
| 08/19/2004 | WO2004069856A1 Process for preparing inhibitors of nucleoside phosphorylases and nucleosidases |
| 08/19/2004 | WO2004069855A1 Novel glycosyl transferase with consideration of activity expression mechanism and method of producing the same |
| 08/19/2004 | WO2004069834A1 Tricyclic compound, process for producing the same, and use |
| 08/19/2004 | WO2004069833A1 Fused-ring pyridine derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069808A1 Acrylamide derivative, process for producing the same, and use |
| 08/19/2004 | WO2004069274A2 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | WO2004069272A2 Adjuvant combination for use in the immunization of a mamal comprising il2 and il12 |
| 08/19/2004 | WO2004069267A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/19/2004 | WO2004069183A2 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | WO2004069173A2 Methods for modulating an inflammatory response |
| 08/19/2004 | WO2004069142A2 Anti-candida agents for the treatment of prion diseases |
| 08/19/2004 | WO2004069134A2 Invert emulsion type composition containing at least one active agent sensitive to the presence of water, and its uses in cosmetics and in dermatology |
| 08/19/2004 | WO2004054973A3 Piperidine and pyrrolidine derivatives as antagonists of histamine h3 receptor |
| 08/19/2004 | WO2003072720A3 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus |
| 08/19/2004 | WO2003049702A8 Vanilloid receptor ligands and their use in treatments |
| 08/19/2004 | US20040162433 Lipoxin A4 analogs |
| 08/19/2004 | US20040162426 TNF (tumor necrosis factor); for treating conditions such as rheumatoid and osteoarthritis, corneal, epidermal or gastric ulceration; tumor metastasis or invasion; periodontal disease and bone disease |
| 08/19/2004 | US20040162314 Enzyme inhibitors of phosphordiesterase 4 having minimal side effects; antiinflammatory agents; antiallergens; asthma; neurodegenerative disorders; antidiabetic agents; pain; anti-tumor, -carcinogenic and -arthritic agents |
| 08/19/2004 | US20040162291 For therapy of cardiovascular disorders and erectile dysfunction |
| 08/19/2004 | US20040162290 For therapy of cancer, benign prostatic hypertrophy or myoma of the uterus, endometriosis, polycystic ovarian disease, uterine fibroids or precocious puberty, lupus erythematosis, irritable bowel syndrome, premenstrual syndrome, hirsutism |
| 08/19/2004 | US20040162287 Substituted cyclohexane-1,4-diamine compounds |
| 08/19/2004 | US20040161843 Administering a peptide fragments from proteins that function as T-cell epitopes of human cytomegalovirus(HCMV) in human are capable of directing human cytotoxic T lymphocytes (CTL) to recognize and lyse human cells to infection with HCMV |
| 08/19/2004 | US20040161806 Cells having transferred proteins, and methods of use thereof |
| 08/19/2004 | US20040161797 for drug screening by assessing the effect on localization of signal transduction proteins, particularly the protein kinase C (PKC) isoenzymes |
| 08/19/2004 | US20040161746 Method of testing allergic disease |
| 08/19/2004 | US20040161458 Hard gelatin capsule containing mixture of surfactants |
| 08/19/2004 | US20040161385 Delivery of beta-blockers through an inhalation route |
| 08/19/2004 | DE10237722A1 Indol- oder Benzimidazolderivate zur Modulation der IKappaB-Kinase Indole or benzimidazole derivatives for the modulation of IkappaB kinase |
| 08/19/2004 | CA2515302A1 Sensitizing cells for apoptosis by selectively blocking cytokines |
| 08/19/2004 | CA2515100A1 Trimeric polypeptide construct to induce an enduring t cell response |
| 08/19/2004 | CA2514641A1 Methods for modulating an inflammatory response |
| 08/19/2004 | CA2513905A1 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | CA2513731A1 Pharmaceutical combinations comprising corticoids and immunosuppressants for treating corticoid- and/or calcineurin inhibitors-resistant diseases |
| 08/18/2004 | EP1447399A1 "2-oxo-1-pyrrolidine derivative and its pharmaceutical uses" |
| 08/18/2004 | EP1447095A1 Preventives and/or remedies for post-transplant arteriosclerosis as rejection of organ transplant |
| 08/18/2004 | EP1446733A2 Glycosylphosphatidylinositol containing polypeptides |
| 08/18/2004 | EP1446487A1 Mammalian protein phosphatases |
| 08/18/2004 | EP1446419A2 Therapeutic polypeptides, nucleic acids encoding the same, and methods of use |
| 08/18/2004 | EP1446385A1 Preparation and use of substituted imidazoles |
| 08/18/2004 | EP1446162A2 Combination motif immune stimulatory oligonucleotides with improved activity |
| 08/18/2004 | EP1446159A2 Immunotherapy for reversing immune suppression |
| 08/18/2004 | EP1446139A2 Pharmaceutical composition containing sfcyr iib or sfcyr iii |
| 08/18/2004 | EP1446136A2 Curcuminoid compositions exhibiting synergistic inhibition of the expression and/or activity of cyclooxygenase-2 |
| 08/18/2004 | EP1446130A2 Ehrlichia canis genes and vaccines |
| 08/18/2004 | EP1446129A2 Polynucleotide therapy |
| 08/18/2004 | EP1446116A1 Inhibitors of dipeptidyl peptidase iv |
| 08/18/2004 | EP1446115A2 Cyanoalkylamino derivatives as protease inhibitors |
| 08/18/2004 | EP1446113A2 Compounds and methods for treating transplant rejection |
| 08/18/2004 | EP1446100A2 Injectable depot compositions and uses thereof |
| 08/18/2004 | EP1446088A2 Intraorally disintegrating valdecoxib compositions prepared by fluid bed granulation process |
| 08/18/2004 | EP1446008A2 Compositions and methods for controlled release |
| 08/18/2004 | EP1315504B1 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 08/18/2004 | EP1286997B1 6-phenylpyrrolopyrimidinedione derivatives |
| 08/18/2004 | EP1212309B1 Caspase inhibitor |
| 08/18/2004 | EP1194109B1 Topical formulations comprising skin penetration agents and the use thereof |
| 08/18/2004 | EP1187814B1 5-phenyl-pyrimidine derivatives |
| 08/18/2004 | EP1117390B1 Mucosal originated drug delivery systems |
| 08/18/2004 | EP0977856B1 Lag-3 splice variants |
| 08/18/2004 | EP0944599B1 Triarylethanes useful as pde iv inhibitors |
| 08/18/2004 | EP0909171B1 Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1 |
| 08/18/2004 | CN1522264A 抗cd40单克隆抗体 Monoclonal antibody anti-cd40 |
| 08/18/2004 | CN1522258A Novel 4-amino-5,6-substituted thiopheno 2,3-d]pyrimidines |
| 08/18/2004 | CN1522257A Thiepino[3,2-b]dihydropyridines and related compositions and methods |
| 08/18/2004 | CN1522254A Immunomodulating compounds |
| 08/18/2004 | CN1522250A Cyclic diamine compound having five-membered cyclic group |
| 08/18/2004 | CN1522248A Novel butadiene derivatives, process for preparation of the same and intermediates for the synthesis thereof |
| 08/18/2004 | CN1522155A Method for producing a vaccine |
| 08/18/2004 | CN1521184A Hepatitis B virus pre-S mutain, and its preparing process and application |
| 08/18/2004 | CN1520885A Room temperature storable immunoglobulin preparation for intravenous injection |
| 08/18/2004 | CN1520884A Immunological regulator and application thereof |
| 08/18/2004 | CN1520879A Chinese caterpillar fungus ginseng dan drop pills and preparing process thereof |
| 08/18/2004 | CN1162427C Amine derivatives compounds as medicament and its salts and esters used for medicine |